bmiMD Review – Cheap on the Countdown, Expensive in the Complaints

bmiMD is a New York-based telehealth platform selling compounded GLP-1 medication and a broad range of adjacent injectables and tablets — NAD+, sermorelin, glutathione, metformin, B12 — to cash-pay customers. Its weight-loss pricing is genuinely competitive at an advertised $99 a month for compounded semaglutide and $139 for tirzepatide, and unlike most of the market it publishes third-party potency testing and promises to hold your rate through renewals. The reason this review lands where it does is what happens after you pay: the complaint record describes charges well above what customers agreed to, cancellations that were not honoured, and orders that never arrived.

Overview

bmiMD operates from 420 Lexington Avenue in New York. The Better Business Bureau records the business as starting on 31 December 2022 and opened its file in December 2023, listing David Dubrino as chief marketing officer. It describes itself as an online portal connecting consumers with physicians for prescription weight loss and wellness services.

The product range is unusually wide for a company of this size. Weight loss covers compounded tirzepatide and semaglutide plus microdosed versions of both, metformin, a lipotropic MIC and vitamin B12 injection, and a naltrexone/bupropion/vitamin B6 combination. Beyond that sit "Mood + Energy", "Strength + Cardio" and "Anti-Aging" categories built around NAD+ injections and nasal spray, sermorelin in three formats, and glutathione injections, with peptides advertised as coming soon.

bmiMD at a Glance

How It Works, Step by Step

1. Free assessment. An online questionnaire that routes you to a suggested plan.
2. Physician review. A licensed physician reviews your submission through the portal.
3. Choose a plan. Medication and term, at whatever promotional rate is running.
4. Payment and rate lock. bmiMD states that the rate you join at holds through every renewal for as long as your membership stays active.
5. Compounding and dispatch. An unnamed state-licensed pharmacy in bmiMD's network prepares the medication, with third-party potency testing performed.
6. Delivery. Shipped to your door on your plan cycle.

Pricing, the Countdown, and the Rate Lock

These were the advertised rates on bmiMD's own site on 6 August 2026, under a banner reading "Summer Closeout" with a countdown timer.

At $99 for compounded semaglutide, bmiMD matches Cora Health's entry price, and at $139 for tirzepatide it sits just above Trimi's $125. On the headline numbers this is a competitive offer.

The Billing and Delivery Complaints

This is the section that determines the rating. The complaint themes recorded against bmiMD are more serious than the ordinary friction we document across this category, because they extend past billing into whether the product arrives at all.

• Charges above the agreed amount. Complaints describe unexpected or excessive charges, in some cases hundreds of dollars above the advertised or agreed figure.
• Cancellations ignored. Confirmed cancellations reportedly not actioned, with automatic charges continuing afterwards.
• Support that cannot be reached. Emails going unanswered for weeks, with no accessible phone line.
• Partial or missing deliveries. Reports of incomplete orders, missing products, and medication never received.
• Post-promotional price shock. The jump from a discounted starter month to full price, described above.

The last-but-one point is the one that separates bmiMD from most providers we criticise. A company that overcharges you has taken your money; a company that does not ship your medication has also interrupted a treatment that should not be interrupted abruptly. With no phone line and email replies measured in weeks, a customer in that position has no fast route to resolution.

For balance: these are complaints, which self-select for bad experiences, and bmiMD has more than 600 Trustpilot reviews including many describing responsive service and problems resolved. The picture is not uniform. But the pattern is specific and repeated, and it concerns the two things a mail-order pharmacy service must get right.

If you use bmiMD, pay with a method that gives you strong chargeback rights, keep written confirmation of your rate and any cancellation, and do not let your supply run to zero before the next delivery is confirmed as shipped.

The Wider Catalogue — Treat With Caution

bmiMD sells considerably more than GLP-1s, and the evidence behind the rest of the range varies from thin to absent. This matters because the assessment funnels route you toward these products by symptom.

• Microdosed GLP-1. Sub-therapeutic dosing of semaglutide or tirzepatide for metabolic or longevity purposes is not an approved use and has limited published evidence. See our microdosing guide.
• Lipotropic MIC + B12. Methionine, inositol and choline injections are long marketed for fat loss with very little supporting clinical evidence. B12 corrects a deficiency; it does not cause weight loss in people who are not deficient.
• Sermorelin. A growth-hormone-releasing analogue promoted here for muscle, anti-ageing and sleep. Use for these purposes is off-label, and the oral and nasal-spray formats raise additional questions about whether a peptide is meaningfully absorbed by those routes.
• NAD+ and glutathione injections. Marketed for energy, focus, detoxification and skin health. These are not FDA-approved for such uses and the human evidence is weak.
• Naltrexone/bupropion. This combination does have an FDA-approved branded form for weight management, but a compounded three-ingredient version is not that product.

None of these are necessarily unsafe under clinical supervision, and none of it is unusual in this corner of telehealth. But a menu that lets you assemble four subscriptions from one questionnaire is a commercial design as much as a clinical one. If you are here for weight loss, there is no good reason to add the rest.

Third-Party Testing: What It Does and Does Not Prove

bmiMD states that its network pharmacies perform third-party testing through FDA- and DEA-registered labs, running quality-control checks on several characteristics including potency, and it publishes test results. That is a real transparency measure and more than most competitors offer — we credit it.

Two qualifications. First, potency and sterility testing tells you the vial contains what it should; it does not make the product FDA-approved, and it is not equivalent to the manufacturing oversight applied to an approved drug. Second, bmiMD still does not name the pharmacy. Published test results from an unnamed facility are harder to verify independently than a named pharmacy with a checkable licence — providers like Cora Health, Trimi and Embody do both.

Eligibility, Contraindications, and Side Effects

bmiMD does not publish eligibility criteria; a physician determines suitability after the free assessment. See our eligibility guide for what a thorough screen should cover.

Semaglutide and tirzepatide carry a boxed warning regarding thyroid C-cell tumours, based on rodent studies. You should not take these medications if you or a family member have had medullary thyroid carcinoma, if you have Multiple Endocrine Neoplasia syndrome type 2, or if you have had a serious hypersensitivity reaction to the active ingredient. They are not for use in pregnancy. A history of pancreatitis, gallbladder disease, gastroparesis or other severe gastrointestinal disease, or diabetic retinopathy, warrants specific discussion first.

Common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and abdominal pain — typically worst after a dose increase. Serious but less common risks include pancreatitis, gallbladder disease and acute kidney injury from dehydration. Bupropion carries its own warnings, including seizure risk and neuropsychiatric effects, and naltrexone interacts seriously with opioids — if you are routed toward that combination, raise both. Our side effects guide covers GLP-1 management.

We are not quoting weight-loss figures for bmiMD, and note that its affiliate materials describe its products as containing "the same active ingredients found in Wegovy® and Zepbound®" — the precise framing the FDA has warned other telehealth companies about, on the basis that it implies an FDA evaluation that has not happened. Our compounded vs brand-name guide explains what actually differs.

Where It Is and Is Not Available

bmiMD is US-only and does not operate in Alabama, Arkansas, California, Kentucky, Louisiana, Mississippi, North Carolina, North Dakota or South Carolina. That is nine states, and it includes California — the largest state in the country, and one whose absence a lot of prospective customers will discover late.

We should be direct that our January 2026 review described bmiMD as operating "across 49 states". That was wrong, and this page corrects it.

Legitimacy and Complaint Record

bmiMD holds a B- rating from the Better Business Bureau and is not BBB accredited. The BBB attributes the rating in part to a failure to respond to a complaint filed against the business, and to the length of time the company has taken to respond to complaints. That is a small number in absolute terms, but non-response is the specific behaviour the complaint record otherwise describes, so it corroborates rather than contradicts it.

On Trustpilot bmiMD has around 604 reviews with genuinely mixed sentiment — praise for responsive service and results alongside accounts of medication causing illness and of being prevented from cancelling. The company advertises more than 80,000 members and a 4.9-star average in its affiliate materials; we could not verify either figure and report them as company claims. The independent 604-review sample and the BBB record are the checkable evidence, and they are weaker than the marketing.

How bmiMD Compares

Trimi is the direct comparison and it wins on every axis except brand recognition: the same $99 semaglutide, cheaper tirzepatide, named pharmacies, all 50 states, and a flat price that is not contingent on never pausing. There is no configuration of preferences we can construct in which bmiMD is the better buy at the same price.

Pros and Cons

Who Should Pick It, and Who Should Look Elsewhere

bmiMD might suit you if the published testing results matter to you more than a named pharmacy, you are in a served state, and you intend to stay on continuously so the rate lock works in your favour. If you go ahead, use a card with strong chargeback protection, get your month-four price in writing, and keep every confirmation.

For most people, look elsewhere. Trimi Health offers the same $99 semaglutide and cheaper tirzepatide with named pharmacies and nationwide coverage. Cora Health and Precision Telemed cost a little more and have far stronger service records. If you live in California or one of the other eight excluded states, this is moot. And if you want an FDA-approved product, NovoCare Pharmacy sells brand-name semaglutide at $149.

Limitations of This Review

This review is based on bmiMD's own site, its BBB profile and independent review coverage, checked on 6 August 2026. The site publishes "as low as" promotional pricing rather than a standard rate card, so the higher standard and post-promotional figures cited here come from third-party reporting we could not verify at source. The complaint themes are drawn from published complaint records and reviews, not from our own experience — we have not signed up, been prescribed, or received medication. We could not identify the compounding pharmacy or independently verify the claimed 80,000 members or 4.9-star average. This review also corrects our January 2026 version, which rated bmiMD 4.1 and stated incorrectly that it served 49 states.

Frequently Asked Questions

Verdict

We have downgraded bmiMD from 4.1 to 2.8, and the reason is not the price, which is good, or the testing, which is genuinely better than most of the market offers. It is that the things customers report going wrong are the things that matter most: money taken that was not agreed, cancellations that did not take effect, and boxes that did not turn up — with no phone number to call about any of it. Trimi Health sells the same medication at the same price, names its pharmacies, covers all fifty states and does not run a permanent countdown clock. Take that instead.